BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34504167)

  • 1. The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer.
    Beveridge DJ; Richardson KL; Epis MR; Brown RAM; Stuart LM; Woo AJ; Leedman PJ
    Sci Rep; 2021 Sep; 11(1):18003. PubMed ID: 34504167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-15b-5p facilitates the tumorigenicity by targeting RECK and predicts tumour recurrence in prostate cancer.
    Chen R; Sheng L; Zhang HJ; Ji M; Qian WQ
    J Cell Mol Med; 2018 Mar; 22(3):1855-1863. PubMed ID: 29363862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation.
    Niture S; Tricoli L; Qi Q; Gadi S; Hayes K; Kumar D
    Tumour Biol; 2022; 44(1):107-127. PubMed ID: 35811549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
    Song Y; Song C; Yang S
    Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
    Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
    BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX30, a target gene of miR-653-5p, represses the proliferation and invasion of prostate cancer cells through inhibition of Wnt/β-catenin signaling.
    Fu Q; Sun Z; Yang F; Mao T; Gao Y; Wang H
    Cell Mol Biol Lett; 2019; 24():71. PubMed ID: 31889959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).
    Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M
    Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC; Nicholson HD; Gold EJ
    Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells.
    He JH; Zhang JZ; Han ZP; Wang L; Lv YB; Li YG
    J Exp Clin Cancer Res; 2014 Sep; 33(1):72. PubMed ID: 25200485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway.
    Song X; Wang H; Wu J; Sun Y
    Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168
    [No Abstract]   [Full Text] [Related]  

  • 12. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
    Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S
    Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer.
    Hirata H; Ueno K; Shahryari V; Deng G; Tanaka Y; Tabatabai ZL; Hinoda Y; Dahiya R
    PLoS One; 2013; 8(1):e55502. PubMed ID: 23383207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p/tribbles homolog 1 pathway.
    Tan X; Song X; Fan B; Li M; Zhang A; Pei L
    Anticancer Drugs; 2022 Oct; 33(9):871-882. PubMed ID: 36136987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
    Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
    Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-361-5p suppresses the tumorigenesis of hepatocellular carcinoma through targeting WT1 and suppressing WNT/β-cadherin pathway.
    Cheng Y; Qiu L; He GL; Cai L; Peng BJ; Cao YL; Pan MX
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8823-8832. PubMed ID: 31696469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer.
    Liu J; Li J; Ma Y; Xu C; Wang Y; He Y
    Bioengineered; 2021 Dec; 12(1):3240-3251. PubMed ID: 34238129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5.
    Yang ZG; Ma XD; He ZH; Guo YX
    Int Braz J Urol; 2017; 43(6):1060-1067. PubMed ID: 28727371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
    Xue D; Lu H; Xu HY; Zhou CX; He XZ
    J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
    Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
    Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.